USD 16.94
(-5.88%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 295.35 Billion JPY | -2.37% |
2023 | 297.92 Billion JPY | 3.96% |
2022 | 286.58 Billion JPY | 13.39% |
2021 | 252.75 Billion JPY | 15.2% |
2020 | 219.4 Billion JPY | 9.03% |
2019 | 201.23 Billion JPY | 14.29% |
2018 | 176.06 Billion JPY | -17.7% |
2017 | 213.92 Billion JPY | -9.85% |
2016 | 237.29 Billion JPY | -9.5% |
2015 | 262.2 Billion JPY | 8.28% |
2014 | 242.15 Billion JPY | 9.62% |
2013 | 220.91 Billion JPY | 6.28% |
2012 | 207.86 Billion JPY | 39.43% |
2011 | 149.08 Billion JPY | 8.75% |
2010 | 137.08 Billion JPY | 10.34% |
2009 | 124.23 Billion JPY | -3.37% |
2008 | 128.57 Billion JPY | 5.36% |
2007 | 122.03 Billion JPY | -0.7% |
2006 | 122.89 Billion JPY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 295.35 Billion JPY | -0.86% |
2024 Q2 | 284.57 Billion JPY | -1.73% |
2024 Q1 | 289.59 Billion JPY | -2.8% |
2024 Q4 | 295.35 Billion JPY | 3.97% |
2024 Q3 | 284.07 Billion JPY | -0.18% |
2023 Q3 | 280.33 Billion JPY | -1.96% |
2023 Q1 | 278.27 Billion JPY | -2.9% |
2023 Q4 | 297.92 Billion JPY | 6.27% |
2023 FY | 297.92 Billion JPY | 3.96% |
2023 Q2 | 285.93 Billion JPY | 2.75% |
2022 Q1 | 250.21 Billion JPY | -1.0% |
2022 Q3 | 276.98 Billion JPY | 2.01% |
2022 FY | 286.58 Billion JPY | 13.39% |
2022 Q2 | 271.51 Billion JPY | 8.52% |
2022 Q4 | 286.58 Billion JPY | 3.47% |
2021 Q3 | 244.43 Billion JPY | 6.68% |
2021 Q1 | 214.24 Billion JPY | -2.35% |
2021 Q4 | 252.75 Billion JPY | 3.4% |
2021 Q2 | 229.12 Billion JPY | 6.95% |
2021 FY | 252.75 Billion JPY | 15.2% |
2020 Q4 | 219.4 Billion JPY | 3.0% |
2020 FY | 219.4 Billion JPY | 9.03% |
2020 Q1 | 197.6 Billion JPY | -1.81% |
2020 Q2 | 195.22 Billion JPY | -1.2% |
2020 Q3 | 213 Billion JPY | 9.11% |
2019 Q1 | 213.75 Billion JPY | 21.41% |
2019 Q2 | 197.97 Billion JPY | -7.38% |
2019 Q4 | 201.23 Billion JPY | 1.04% |
2019 FY | 201.23 Billion JPY | 14.29% |
2019 Q3 | 199.16 Billion JPY | 0.6% |
2018 Q2 | 199.7 Billion JPY | -5.71% |
2018 FY | 176.06 Billion JPY | -17.7% |
2018 Q4 | 176.06 Billion JPY | 0.53% |
2018 Q3 | 175.14 Billion JPY | -12.3% |
2018 Q1 | 211.8 Billion JPY | -0.99% |
2017 Q2 | 219.73 Billion JPY | -2.88% |
2017 FY | 213.92 Billion JPY | -9.85% |
2017 Q3 | 231.07 Billion JPY | 5.16% |
2017 Q1 | 226.24 Billion JPY | -4.66% |
2017 Q4 | 213.92 Billion JPY | -7.42% |
2016 Q2 | 264.7 Billion JPY | -0.35% |
2016 Q4 | 237.29 Billion JPY | -2.06% |
2016 Q3 | 242.29 Billion JPY | -8.47% |
2016 FY | 237.29 Billion JPY | -9.5% |
2016 Q1 | 265.63 Billion JPY | 1.31% |
2015 Q2 | 249.52 Billion JPY | 5.77% |
2015 Q1 | 235.91 Billion JPY | -2.58% |
2015 Q3 | 258.03 Billion JPY | 3.41% |
2015 Q4 | 262.2 Billion JPY | 1.61% |
2015 FY | 262.2 Billion JPY | 8.28% |
2014 Q1 | 222.99 Billion JPY | 0.94% |
2014 FY | 242.15 Billion JPY | 9.62% |
2014 Q3 | 237.47 Billion JPY | 4.1% |
2014 Q4 | 242.15 Billion JPY | 1.97% |
2014 Q2 | 228.12 Billion JPY | 2.3% |
2013 Q3 | 213.46 Billion JPY | 7.57% |
2013 Q4 | 220.91 Billion JPY | 3.49% |
2013 FY | 220.91 Billion JPY | 6.28% |
2013 Q1 | 200.35 Billion JPY | -3.61% |
2013 Q2 | 198.44 Billion JPY | -0.95% |
2012 FY | 207.86 Billion JPY | 39.43% |
2012 Q2 | 150.45 Billion JPY | 1.34% |
2012 Q3 | 196.44 Billion JPY | 30.57% |
2012 Q4 | 207.86 Billion JPY | 5.81% |
2012 Q1 | 148.46 Billion JPY | -0.41% |
2011 Q1 | 139.39 Billion JPY | 1.68% |
2011 FY | 149.08 Billion JPY | 8.75% |
2011 Q2 | 148.42 Billion JPY | 6.48% |
2011 Q3 | 144.02 Billion JPY | -2.96% |
2011 Q4 | 149.08 Billion JPY | 3.51% |
2010 Q2 | 129.32 Billion JPY | 0.0% |
2010 FY | 137.08 Billion JPY | 10.34% |
2010 Q4 | 137.08 Billion JPY | 5.41% |
2010 Q3 | 130.05 Billion JPY | 0.56% |
2009 Q3 | 117.56 Billion JPY | 0.0% |
2009 Q4 | 124.23 Billion JPY | 5.68% |
2009 FY | 124.23 Billion JPY | -3.37% |
2008 FY | 128.57 Billion JPY | 5.36% |
2007 FY | 122.03 Billion JPY | -0.7% |
2006 FY | 122.89 Billion JPY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Bio Medica Corporation | 1.26 Million USD | -23274604.492% |
Arrayit Corporation | 1 Million USD | -29524015.119% |
Atlantic International Corp. | 4.43 Million USD | -6657518.71% |
Biocept, Inc. | 30.87 Million USD | -956580.595% |
Bioqual, Inc. | 56.58 Million USD | -521842.154% |
CardioGenics Holdings Inc | 231.93 Thousand USD | -127345846.226% |
DermTech, Inc. | 121.93 Million USD | -242134.069% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | -6957.531% |
HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -1661288.974% |
iMD Companies, Inc. | 190.13 Thousand USD | -155338419.068% |
IDenta Corp. | 1.52 Million USD | -19313365.531% |
Interpace Biosciences, Inc. | 13.02 Million USD | -2268205.046% |
Integrative Health Technologies, Inc. | 8.25 Million USD | -3579142.777% |
InVitro International | 1.53 Million USD | -19253788.672% |
Lumos Diagnostics Holdings Limited | 26.83 Million USD | -1100414.196% |
Many Bright Ideas Technologies Inc. | 2312.00 USD | -12774913394.81% |
Medical Imaging Corp. | 4.19 Million USD | -7046233.083% |
NovelStem International Corp. | 2.25 Million USD | -13100364.572% |
Optigenex Inc. | 1.88 Million USD | -15641353.378% |
PharmChem, Inc. | 2.76 Million USD | -10679693.85% |
Proteome Sciences plc | 14.58 Million USD | -2024823.432% |
Response Genetics, Inc | 48.88 Million USD | -604097.692% |
Rennova Health, Inc. | 20.57 Million USD | -1435565.274% |
RushNet, Inc. | 6.04 Million USD | -4883752.33% |
ScreenPro Security Inc. | 1.26 Million USD | -23415596.879% |
Stella Diagnostics Inc. | 472.42 Thousand USD | -62519294.695% |
StageZero Life Sciences Ltd. | 700.65 Thousand USD | -42154350.426% |
Todos Medical Ltd. | 15.26 Million USD | -1934504.048% |